Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 9Phase 3 2Phase 1/2 2

Status

Recruiting 5Completed 3Unknown 2Not yet recruiting 2Active not recruiting 2

Sponsor Class

UNKNOWN 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Radiation Dose Hypofractionation × Clear all
NCT03778541 2019-07-23

HFSRT With Concurrent TMZ for Large BMs

ChineseAMS

Phase 3 Unknown
224 enrolled
CNS

Brain Neoplasms

NCT03319069 2017-10-24

Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer

Assiut University

Phase 3 Unknown
60 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡